# Tenofovir Alafenamide in HBV Related Decompensated Liver

> **NCT04683341** · PHASE4 · UNKNOWN · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 100 (estimated)

## Conditions studied

- HBV

## Interventions

- **DRUG:** Tenofovir Alafenamide Tablets

## Key facts

- **NCT ID:** NCT04683341
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2021-01-31
- **Final completion:** 2025-04-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04683341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04683341, "Tenofovir Alafenamide in HBV Related Decompensated Liver". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04683341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*